Clinical Trials in New York

Showing 621-640 of 19,464 trials

A Study of ZL-1310 in Participants With Selected Solid Tumors

NCT06885281

A Phase 1b/2, Open-label, Multi-center Study of ZL-1310 in Participants With Selected Solid Tumors

Zai Lab (Shanghai) Co., Ltd.112 participantsStarted May 2025

San Francisco, California, United States • Detroit, Michigan, United States • New York, New York, United States +17 more locations

RECRUITING< 1 mile

Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders

NCT06839469

The purpose of this research is (1) to identify disease specific walking-related digital biomarkers of disease severity, and (2) monitor longitudinal changes in natural environments, for extended periods of time, in DMD and SMA.

Spinal Muscular Atrophy Type 3Duchenne Muscular Dystrophy (DMD)

Columbia University106 participantsStarted May 2024

Palo Alto, California, United States • Boston, Massachusetts, United States • New York, New York, United States

A Study of ZL-1310 in Participants With Selected Solid Tumors

Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders

Find Trials by Condition in New York

CHAMPION-AF Clinical Trial

Packed Red Blood Cell Transfusion During Cardiac Arrest

LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer

A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis

A Study About the Long-Term Safety of TAK-881 in People With Primary Immunodeficiency Diseases

A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes

An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Fumarate-based RMS Approved Therapies or Fingolimod to Ofatumumab

Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm

Short-Term Safety of Low-Dose Creatine Hydrochloride: A 28-Day Single-Arm Pilot Study

FSL2 Post Approval Study for Pediatric and Young Adults Patients

A Study of Dazostinag as Single Agent and Dazostinag in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors

Multisystemic Therapy-Emerging Adults (MST-EA) for Substance Abuse

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both

Education & Mentorship of Advanced Practice Providers to Increase Community-based Research Within the NCORP Network, COACH-APP Trial

A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy

Understanding Needs of Older Patients Prior to Starting Cancer Treatment